NEW YORK, September 24, 2015 /PRNewswire/ --

ACI Association has initiated research coverage on the following equities: Concert Pharmaceuticals, Inc.  (NASDAQ: CNCE), Clovis Oncology, Inc. (NASDAQ: CLVS), bluebird bio, Inc. (NASDAQ: BLUE), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), DENTSPLY International Inc. (NASDAQ: XRAY). On Wednesday, September 23, 2015, NASDAQ ended at 4,752.74 down 0.08%, Dow Jones declined 0.31%, to finish the day at 16,279.89, and the S&P closed at 1,938.76, down 0.20%. Register for your complimentary reports at the links given below.

--

Concert Pharmaceuticals Inc.  

--

Concert Pharmaceuticals Inc.'s stock edged higher by 23.14% to close Wednesday's session at USD 22.46. The company's shares oscillated between USD 18.35 and USD 22.80. The stock recorded a trading volume of 2.05 million shares, which was above its 50-day daily average volume of 0.29 million shares. Over the last three days, Concert Pharmaceuticals Inc.'s shares have advanced 12.19% and in the past one week it has moved up 21.54%. Furthermore, over the last three months, the stock has gained 38.39% and in the past six months, the shares have picked up 65.39%. On a compounded total return basis, the stock has returned 45.94% in the past one month and 44.72% in the past three months. Sign up and read the free notes on CNCE at:  http://www.aciassociation.com/CNCE.pdf

--

Clovis Oncology Inc.  

--

The stock of Clovis Oncology Inc. lost 0.52% to close Wednesday's session at USD 99.72. The shares of the company moved in the range of USD 96.59 and USD 102.30. A trading volume of 1.27 million shares was recorded, which was greater than its 150-day daily average volume of 0.73 million shares. Over the last five days, Clovis Oncology Inc.'s shares have declined by 8.27% but in the past one month, it has gained a momentum of 37.20%. Additionally, over the last three months, the stock has advanced 16.10% and in the past six months, the company's shares have registered a profit of 38.48%. Further, the stock has returned 37.20% in the past one month, and 12.91% in the last three months, on a compounded total return basis. Register for free on ACI Association and access the latest research on CLVS at:  http://www.aciassociation.com/CLVS.pdf

--

bluebird bio Inc.  

--

bluebird bio Inc.'s stock decreased by 5.40% to close Wednesday's session at USD 113.37. The company's shares fluctuated in the range of USD 112.00 and USD 120.50. A total of 1.17 million shares exchanged hands, which surpassed its 50-day daily average volume of 0.79 million shares. Over the last three days bluebird bio Inc.'s shares have declined by 19.68% and in the past one week it has moved down 14.59%. Furthermore, over the last three months, the stock has lost 33.35%, however, in the past six months; the shares have picked up 2.67%. The company has shown a negative return of 34.96% in the past three months, and of 5.52% in the last half year, on a compounded total return basis. The company is having a market capitalization of USD 4,111.21 million. The complete research on BLUE is available for free at:  http://www.aciassociation.com/BLUE.pdf

--

ACADIA Pharmaceuticals Inc.  

--

ACADIA Pharmaceuticals Inc.'s stock slipped by 0.71% to close Wednesday's session at USD 37.85. The company's shares oscillated between USD 36.88 and USD 38.90. The stock recorded a trading volume of 1.07 million shares, which was below its 50-day daily average volume of 1.30 million shares. Over the last five days, ACADIA Pharmaceuticals Inc.'s shares have declined by 11.28% however in the past one month, it has gained a momentum of 6.17%. In addition, over the last three months, the stock has lost 11.36% and year to date; the shares have picked up 19.21%. The company has returned 11.36% in the last six months, and 41.07% in the past one year, on a compounded total return basis. The stock is at a price to book ratio of 14.87, while the historical PB ratio is near to 10.26. Free in-depth research on ACAD is available at:  http://www.aciassociation.com/ACAD.pdf

--

DENTSPLY International Inc.  

--

DENTSPLY International Inc.'s stock advanced 0.88% to close Wednesday's session at USD 52.97. The share price vacillated between USD 52.18 and USD 53.15. The stock recorded a trading volume of 1.05 million shares, which was above its 50-day daily average volume of 0.97 million shares. Over the last three days DENTSPLY International Inc.'s shares have advanced 0.21% and in the past one week it has moved down 0.19%. On a compounded total return basis, the company has returned 2.45% in the last half a year, and 15.23% in the past one year. DENTSPLY International Inc. has a current dividend yield of 0.55%. The company is trading at a price to earnings ratio of 28.33, compared to a historical PE ratio of 23.80. Further, the stock is at a price to book ratio of 3.20, while the historical PB ratio is near to 3.23. The complimentary notes on XRAY can be downloaded in PDF format at:  http://www.aciassociation.com/XRAY.pdf

--

About ACI Association: 

Active Charter Investors Association ("ACI Association") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. ACI Association has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

ACI Association has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:  

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). Rohit Tuli, a CFA(R) charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY 

ACI Association, the Author, the Reviewer and the Sponsor (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither ACI Association nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.aciassociation.com.

RESTRICTIONS 

ACI Association is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE www.aciassociation.com